Amgen
Registered Principal Details
Business Or Interest:
Pharmaceutical manufacturing
Lobbying Interests:
All matters relating to the pharmaceuticals and health care industries
CEO Name:
Robert Bradway
Executive Director
Pharmaceutical manufacturing
Lobbying Interests:
All matters relating to the pharmaceuticals and health care industries
CEO Name:
Robert Bradway
Executive Director
Contact
KS
Kathy Sherman
601 13th Street, NW, 12th Floor
Washington, DC 20005
(202) 585-9614
(202) 585-9729
kathy.sherman@amgen.com
601 13th Street, NW, 12th Floor
Washington, DC 20005
(202) 585-9614
(202) 585-9729
kathy.sherman@amgen.com
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|---|---|---|
| John Benske | Exclusive Duties N/A | Authorized On 5/31/2017 | Withdrawn On 9/1/2017 |
| Scott Stenger | Exclusive Duties N/A | Authorized On 12/12/2017 | Withdrawn On N/A |
| Kevin Johnson | Exclusive Duties N/A | Authorized On 6/12/2018 | Withdrawn On N/A |
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 679
Toggle details
Assembly Bill 679
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
Bill Text and History
12/12/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
Bill Text and History
For
Notification Date12/12/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 575
Toggle details
Senate Bill 575
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
Bill Text and History
2017 Wisconsin Act 149
12/12/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
Bill Text and History
2017 Wisconsin Act 149
For
Notification Date12/12/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
Substitution of interchangeable biosimilars
Substitution of interchangeable biosimilars
Action Intended To Affect
Both Legislative matter and rule
Notification Date
7/19/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
7/19/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total | |
|---|---|---|---|---|---|
| Total Lobbying Expenditures | 2017 January - June $0.00 |
2017 July - December $7,117.61 |
2018 January - June $12,000.00 |
2018 July - December $440.67 |
Total $19,558.27 |
| Total Hours Communicating | 2017 January - June 0.00 |
2017 July - December 4.00 |
2018 January - June 9.00 |
2018 July - December 0.00 |
Total 13.00 |
| Total Hours Other | 2017 January - June 0.00 |
2017 July - December 35.00 |
2018 January - June 23.50 |
2018 July - December 3.50 |
Total 62.00 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December 30% |
2018 January - June 40% |
2018 July - December |
Total 33% |
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December 30% |
2018 January - June 60% |
2018 July - December |
Total 43% |
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December 40% |
2018 January - June |
2018 July - December |
Total 21% |
Minor Efforts
No minor efforts found.
Other Matters
Includes time spent on:
- Gubernatorial nominations
- Matters on which the organization made no lobbying communication